January 2, 2019
Stress Keeping You Up at Night? Blame Your HPA Axis
New research into our master “circadian clock” explains why your body responds differently to stress at different times of day.
LEARN MORE
December 27, 2018
Biomarkers for Dementia and Alzheimer’s Disease
Over 47 million people worldwide are living with dementia, the great majority of them due to Alzheimer’s disease (AD). ...
LEARN MORE
December 24, 2018
NASH 2018 Review: Improving Awareness and Potential New Therapies
A look back at NASH over the course of 2018, with a focus on raising disease awareness and an update on clinical trial ...
LEARN MORE
December 20, 2018
Immunotherapy 2018 Review: From the Nobel Prize to Clinical Trial Failures
2018 has been a roller coaster year for immunotherapy, from exciting Nobel Prize news to warning IDO1 clinical trial ...
LEARN MORE
December 18, 2018
3 Tips to Navigate a PDX Database
Find out how to select the right patient-derived xenograft model database for you, and which features to use for quick ...
LEARN MORE
December 13, 2018
Obesity, Cancer Development, and Immunotherapy Response
How does obesity impact cancer development and immunotherapy response? Find out in our review of cutting-edge combined ...
LEARN MORE
December 11, 2018
Preclinical Applications for Non-Invasive Imaging Technologies
In this introduction to preclinical imaging, we explore optical imaging technologies, such as bioluminescent and fluorescent imaging, and their applications to in vivo preclinical oncology models and cancer drug development.
LEARN MORE
December 6, 2018
Exercise, Liver Cancer, and NAFLD Mortality
Our current understanding of the mechanisms linking obesity and liver cancer is poor. Preclinical research links ...
LEARN MORE
December 4, 2018
Preclinical Immunotherapy Safety and Toxicity Assessment
While the overall objectives for preclinical evaluation of cancer immunotherapies are identical to other anticancer ...
LEARN MORE
November 29, 2018
Where Do Organoids Fit in Preclinical Cancer Modeling?
There’s a wide range of new preclinical cancer models being developed, each with their own strengths and best uses. ...
LEARN MORE
November 27, 2018
Advances in Type 1 Diabetes Research and Treatment
Review the latest cutting-edge advances in type 1 diabetes including an oral anti-diabetes agent, the artificial pancreas, and precision medicine updates.
LEARN MORE
November 22, 2018
Are Cancer Stem Cells a Prime Target for Therapy?
Cancer stem cells (CSC) represent one of the most challenging targets for cancer therapy today. Here we review the ...
LEARN MORE
November 20, 2018
Bioelectronic Medicine and Autoimmune Diseases
Is bioelectronic medicine the future of treatment for autoimmune diseases like lupus, rheumatoid arthritis, and Crohn’s ...
LEARN MORE
November 15, 2018
Prostate Cancer PDX Models and Oncology Analysis Studies: ENA 2018
This week at ENA 2018, we’re presenting up to date research on our PDX models, including our newly developed prostate ...
LEARN MORE
November 15, 2018
Murine Immuno-Oncology Models: ENA 2018
At ENA 2018 we’re presenting new data on our wide range of immuno-oncology (I/O) platforms, with four posters covering ...
LEARN MORE
